Intellia Therapeutics (NTLA) Q3 2023 Earnings

9NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-1.5
-1.39
-1.28
-1.17

Details

Expected EPS
-1.5
Actual EPS
-1.38
Surprise EPS
0.12
Surprise Percent
+8%

Description

Intellia Therapeutics (NTLA) has reported earnings of -1.38 per share for Q3 2023.

0 Comments

Share your thoughts